Arthur T. Sands
2010 - Lexicon Pharmaceuticals
In 2010, Arthur T. Sands earned a total compensation of $1.9M as President, Chief Executive Officer and Director at Lexicon Pharmaceuticals, a 9% increase compared to previous year.
Compensation breakdown
| Bonus | $70,000 |
|---|---|
| Option Awards | $1,127,381 |
| Salary | $577,500 |
| Stock Awards | $140,030 |
| Other | $6,855 |
| Total | $1,921,766 |
Sands received $1.1M in option awards, accounting for 59% of the total pay in 2010.
Sands also received $70K in bonus, $577.5K in salary, $140K in stock awards and $6.9K in other compensation.
Rankings
In 2010, Arthur T. Sands' compensation ranked 3,186th out of 10,439 executives tracked by ExecPay. In other words, Sands earned more than 69.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,186 out of 10,439 | 70th |
Division Manufacturing | 1,110 out of 3,838 | 71st |
Major group Chemicals And Allied Products | 213 out of 921 | 77th |
Industry group Drugs | 114 out of 680 | 83rd |
Industry Pharmaceutical Preparations | 89 out of 481 | 82nd |
Source: SEC filing on March 25, 2013.
Sands' colleagues
We found seven more compensation records of executives who worked with Arthur T. Sands at Lexicon Pharmaceuticals in 2010.
2010
Brian Zambrowicz
Lexicon Pharmaceuticals
Chief Scientific Officer
2010
Jeffrey Wade
Lexicon Pharmaceuticals
Chief Financial Officer
2010
Alan Main
Lexicon Pharmaceuticals
Executive Vice President of Pharmaceutical Research
2010
Philip Brown
Lexicon Pharmaceuticals
Former Senior Vice President, Clinical Development
2010
James Tessmer
Lexicon Pharmaceuticals
Vice President, Finance and Accounting
2010
Steven Tragash
Lexicon Pharmaceuticals
Former Senior Vice President of Corporate Affairs
2010
Ajay Bansal
Lexicon Pharmaceuticals
Chief Financial Officer
News
Nurix Therapeutics CEO Arthur Sands' 2023 pay falls 54% to $4.4M
March 27, 2024
Nurix Therapeutics CEO Arthur Sands' 2022 pay jumps 97% to $9.4M
March 24, 2023
Nurix Therapeutics COO Stefani Wolff receives $7.1M in 2021
March 25, 2022
Nurix Therapeutics CEO Arthur Sands' 2020 pay jumps 1,041% to $17M
March 25, 2021